Department of Psychology, University of Colorado Denver, Denver, CO 80217, USA.
J Psychosoc Oncol. 2011;29(5):475-98. doi: 10.1080/07347332.2011.599359.
Identifying cancer patients who are experiencing psychosocial challenges during the early phase of oncology treatment can prevent escalating patient distress. Standardized screening methods allow the medical team to identify those at high risk for poor adjustment. The purpose of this study was to provide preliminary psychometric evidence for a brief, self-administered screening instrument, the Psycho-Oncology Screening Tool (POST), designed to evaluate emotional and physical distress, depressive symptoms, and social concerns. Participants included 944 radiation oncology patients who completed the POST prior to their treatment appointment and a subgroup of 516 patients who completed the POST and one of six concurrent validity measures. Psychometric analysis included construct validity evidence provided through confirmatory factor analysis (CFA), internal reliability estimates, and concurrent validity estimates assessed with bivariate correlations between POST subscales scores and conceptually similar established measures. A three-factor CFA model was found to produce acceptable model fit, supporting the three domain structure of the POST. Furthermore, the three subscales--emotional and physical distress, depressive symptoms and social concerns--were found to produce acceptable internal reliability estimates (α = .73-.88). Concurrent validity evidence was observed with significant, moderate to large correlations between the POST subscales and all relevant measures (i.e., Profile of Mood States, Hospital Anxiety and Depression Scale, Functional Assessment of Cancer Therapy Fatigue, Beck Depression Inventory, Pain Disability Index, and the Interpersonal Support Evaluation List) with correlations ranged from 0.42 to 0.83, p < 0.01. Patients and clinic staff reported no problems administering or completing the POST. Results of this study support the psychometric soundness as well as the feasibility and acceptability of the POST as a brief screening tool for oncology patients receiving outpatient services.
在肿瘤治疗的早期阶段识别出正在经历心理社会挑战的癌症患者,可以防止患者的痛苦加剧。标准化的筛查方法使医疗团队能够识别出那些适应不良风险较高的患者。本研究的目的是为一种简短的、自我管理的筛查工具——心理肿瘤学筛查工具(POST)提供初步的心理测量证据,该工具旨在评估情绪和身体困扰、抑郁症状和社会问题。参与者包括 944 名接受放射肿瘤治疗的患者,他们在治疗预约前完成了 POST,其中 516 名患者完成了 POST 并完成了 6 项同时有效性测量中的一项。心理测量分析包括通过验证性因素分析(CFA)提供的结构有效性证据、内部可靠性估计值,以及通过 POST 分量表得分与概念上相似的已建立测量之间的双变量相关性评估的同时有效性估计值。发现三因素 CFA 模型产生了可接受的模型拟合度,支持 POST 的三个领域结构。此外,三个分量表——情绪和身体困扰、抑郁症状和社会问题——产生了可接受的内部可靠性估计值(α=0.73-0.88)。在 POST 分量表和所有相关测量之间观察到了同时有效性证据,具有显著的、中等至较大的相关性(即,心境剖面图、医院焦虑和抑郁量表、癌症治疗疲劳功能评估量表、贝克抑郁量表、疼痛残疾指数和人际关系支持评估列表),相关性范围为 0.42 至 0.83,p<0.01。患者和诊所工作人员报告在管理或完成 POST 方面没有问题。这项研究的结果支持 POST 作为一种用于接受门诊服务的肿瘤患者的简短筛查工具的心理测量学稳健性以及可行性和可接受性。